Search for: "United States v. Dow" Results 1 - 20 of 466
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
6 Apr 2012, 10:00 am by Evidence ProfBlogger
Merrell Dow Pharmaceuticals, 509 U.S. 579 (1993), the United States Supreme Court drove a stake through the heart of the old Frye test for the admissibility of expert evidence at the federal level. [read post]
31 Oct 2016, 7:18 am by Evidence ProfBlogger
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the United States Supreme Court replaced the old Frye test for determining the admissibility of expert evidence with the new Daubert, pursuant to which judges serve as gatekeepers and... [read post]
22 Mar 2017, 5:15 am by Cheryl Beise
Dow AgroSciences LLC, United States Court of Appeals, Federal Circuit, No. 2015-1854, 17 March 2017 appeared first on Kluwer Patent Blog. [read post]
9 May 2011, 4:00 am by Ted Folkman
Dow and Dole refused to make the deposits required by the Nicaraguan statute and waived their defenses under the forum non conveniens doctrine to trial in the United States. [read post]
24 Feb 2016, 9:59 am by Gene Quinn
On January 29, 2016, the United States Court of Appeals issued a decision in AKZO Nobel Coatings, Inc. v. [read post]
2 Nov 2010, 11:27 am by Gene Quinn
This could set up a contentious and public policy battle between the United States Department of Commerce and the United States Department of Justice. [read post]
3 Mar 2011, 12:45 pm by WIMS
Appealed from the United States District Court for the District of Maryland. [read post]
17 Nov 2018, 12:10 pm by Schachtman
Indeed, their brief in other places states their opinion that significance testing is not necessary at all: “Testing for significance, however, is often mistaken for a sine qua non of scientific inference. [read post]